Julian Panés

Cap de la Unitat

jpanes@clinic.cat 0000-0002-4971-6902

Publicacions destacades

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease

Autors:
Ordas, Ingrid; Rimola, Jordi; Alfaro, Ignacio; Rodriguez, Sonia; Castro-Poceiro, Jesus;

(...)

Barastegui, Rebeca; Fernandez-Clotet, Agnes; Masamunt, Maica; Ricart, Elena; Panes, Julian.

Referència: Gastroenterology 2019.
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

Autors:
Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W;

(...)

Diez MC; Tagarro I; Leselbaum A; Danese S; ADMIRE CD Study Group Collaborators.

Referència: Gastroenterology 2018.
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis

Autors:
Dotti, Isabella; Mora-Buch, Rut; Ferrer-Picon, Elena; Planell, Nuria; Jung, Peter;

(...)

Llach, Josep; Ordas, Ingrid; Batlle, Eduard; Panes, Julian; Salas, Azucena.

Referència: Gut 2017.
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.

Autors:
Panés J; Sandborn WJ; Schreiber S; Sands BE; Vermeire S;

(...)

Wang W; Niezychowski W; Marren A; Healey P; Maller E .

Referència: Gut 2017.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Autors:
Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine;

(...)

Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian;OCTAVE Induction 1 OCTAVE Inductio.

Referència: New England Journal Of Medicine 2017.
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease

Autors:
Jauregui-Amezaga, Aranzazu; Rovira, Montserrat; Marin, Pedro; Salas, Azucena; Pino-Donnay, Susana;

(...)

Ramirez-Morros, Anna; Gallego, Marta; Ordas, Ingrid; Panes, Julian; Ricart, Elena.

Referència: Gut 2016.
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile

Autors:
Calderon-Gomez, Elisabeth; Bassolas-Molina, Helena; Mora-Buch, Rut; Dotti, Isabella; Planell, Nuria;

(...)

Ordas, Ingrid; Singh, Sharat; Panes, Julian; Benitez-Ribas, Daniel; Salas, Azucena;.

Referència: Gastroenterology 2016.
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial

Autors:
Panes J; Garcia-Olmo D; Van Assche G; Colombel JF; Reinisch W;

(...)

de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S.

Referència: Lancet 2016.
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease

Autors:
Rimola, J; Rodriguez, S; Garcia-Bosch, O; Ordas, I; Ayala, E;

(...)

Pellise, M; Ayuso, C; Ricart, E; Donoso, L; Panes, J.

Referència: Gut 2009.

Projectes destacats

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Investigador/a principal: Maria Azucena Salas Martinez, Julian Panes Diaz

Finançador: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)

Codi: RTI2018-096946-B-I00

Durada: 01/01/2019 - 31/12/2021
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease

Investigador/a principal: Elena Ricart

Finançador: Instituto de Salud Carlos III (Programa financiador competitivo)

Codi: PI17/00513

Durada: 01/01/2018 - 31/12/2020
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues

Investigador/a principal: Maria Azucena Salas Martinez

Finançador: The Leona M and Harry B Helmsley Charitable Trust

Codi: Hemsley

Durada: 02/01/2014 - 31/12/2017
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3

Investigador/a principal: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes Diaz

Codi: NEW DEAL H2020

Durada: 01/01/2017 - 31/12/2020
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)

Investigador/a principal: Julian Panes Diaz

Codi: SAF 2012-33560

Durada: 02/01/2013 - 31/12/2015

Julian Panés

Publicacions destacades

Projectes destacats

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease

IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues

New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3

Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)

Subscriu-te a la Newsletter del Clínic